Home/Filings/4/0001127602-23-023580
4//SEC Filing

Mandadi Tilak 4

Accession 0001127602-23-023580

CIK 0000064803other

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 4:22 PM ET

Size

6.8 KB

Accession

0001127602-23-023580

Insider Transaction Report

Form 4
Period: 2023-08-31
Mandadi Tilak
EVP, Chief Experience & Tech
Transactions
  • Tax Payment

    Common Stock

    2023-08-31$65.17/sh13,053$850,66420,229 total
Holdings
  • Common Stock (RSU)

    66,565
  • Stock Option

    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01Common Stock (96,496 underlying)
    96,496
Footnotes (3)
  • [F1]Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
  • [F2]Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 8/31/2023.
  • [F3]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001872827

Filing Metadata

Form type
4
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:22 PM ET
Size
6.8 KB